Low-dose naltrexone: harnessing the body's own chemistry to treat human ovarian cancer.

  • Published 2011 in Experimental biology and medicine

Abstract

Sorry, we couldn't extract an abstract for this paper.

Topics

  • Presentations referencing similar topics